tiprankstipranks
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Canadian Market
NEVI
Pascal Biosciences Inc
RESEARCH TOOLSreports

Pascal Biosciences Inc (NEVI) Income Statement

5 Followers

Pascal Biosciences Inc Income Statement

Last quarter (Q4 2025), Pascal Biosciences Inc's total revenue was C$381.75K, a decrease of -8.31% from the same quarter last year. In Q4, Pascal Biosciences Inc's net income was C$-238.08K. See Pascal Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 25Feb 25Feb 24Nov 22Feb 22
Total Revenue
C$ 1.70MC$ 1.55MC$ 671.54KC$ 0.00C$ 0.00
Gross Profit
C$ 396.31KC$ 1.08MC$ 392.94KC$ -8.29KC$ -16.32K
Operating Expenses
C$ 686.76KC$ 1.30MC$ 1.26MC$ 548.59KC$ 1.06M
Depreciation and Amortization
C$ 257.79KC$ 251.42KC$ 106.94KC$ 8.29KC$ 16.32K
EBITDA
C$ -32.66KC$ -48.07KC$ -271.56KC$ -468.09KC$ -1.07M
Operating Income
C$ -290.45KC$ -220.15KC$ -868.13KC$ -556.88KC$ -1.08M
Other Income/Expenses
C$ 15.38KC$ -142.33KC$ 468.36KC$ 25.35KC$ -7.87K
Pretax Income
C$ -275.07KC$ -362.48KC$ -399.77KC$ -480.28KC$ -1.09M
Net Income
C$ -275.07KC$ -362.48KC$ -399.77KC$ -480.28KC$ -1.09M
Per Share Metrics
Basic EPS
C$ >-0.01C$ -0.01C$ -0.02C$ -0.04C$ -0.09
Diluted EPS
C$ >-0.01C$ -0.01C$ -0.02C$ -0.04C$ -0.09
Weighted Average Shares Outstanding
 39.66M 38.33M 23.53M 13.11M 12.70M
Weighted Average Shares Outstanding (Diluted)
 39.66M 38.33M 23.53M 13.11M 12.70M
Currency in CAD

Pascal Biosciences Inc Earnings and Revenue History